ESOU 2019: Adjuvant therapy after nephrectomy for high-risk renal cell carcinoma

The following presentations were given at the European Association of Urology (EAU) Section of Oncological Urology (ESOU) conference in Prague, Czech Republic last week. The first presentation approached the discussion of adjuvant therapy after nephrectomy for high-risk renal cell carcinoma (RCC) from a urologist’s perspective, while the second presentation presents the oncologist’s perspective.

Read the urologist’s perspective in UroToday here

Read the oncologist’s perspective in UroToday here

Share this Post!


Related post

  TOP